| RLAY Average Annual Return Chart Since 2020 | |||
Also see: • RLAY stock yearly return 2021 • RLAY stock yearly return 2022 • RLAY stock yearly return 2023 • RLAY stock yearly return 2024 • RLAY YTD return | |||
| Average Annual Return Benchmarks |
|
Compare RLAY average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| RLAY Share Performance |
| RLAY Average Annual Return Table Since 2020 | ||||||||||||||||||||||||||||||
RLAY average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| About Relay Therapeutics Inc |
| Relay Therapeutics Inc. is a clinical-stage precision medicine company. Co. is focused on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. Co.'s Dynamo platform integrates an array of computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. Co.'s lead product candidates, such as RLY-2608, Lirafugratinib (RLY-4008), and Migoprotafib (GDC-1971). RLY-2608 is an allosteric, pan-mutant and isoform-selective phosphoinostide 3 kinase alphas (PI3K?), inhibitor. The RLAY average annual return since 2020 is shown above.
The Average Annual Return on the RLAY average annual return since 2020 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends. Thus, researching Average Annual Returns is good practice for investors — whether RLAY average annual return since 2020 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the RLAY average annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| RLAY Current Stock Quote |
 Free RLAY Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Average Annual Return! | |
|
| Average Annual Return Peers |
| Relay Therapeutics (RLAY) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
RLMD Average Annual Return |
Video: Don't Forget Dividends in Average Annual Return!